CROI 2016 Program at a Glance

Program and Agenda

771 Effect of Pregnancy on Response to Antiretroviral Therapy Among AfricanWomen Athena P. Kourtis 1 ; JeffreyWiener 1 ; Renee Heffron 2 ; Nelly R. Mugo 3 ; Caroline King 1 ; Kavita Nanda 4 ; Connie M. Celum 2 ; Deborah Donnell 5 ; Jairam R. Lingappa 2 ; Jared M. Baeten 2 1 CDC,Atlanta,GA,USA; 2 UnivofWashington,Seattle,WA,USA; 3 Kenya MedRsr Inst,Thika,Kenya; 4 FHI361,ChapelHill,NC,USA; 5 SCHARP,Fred HutchinsonCancerRsrCntr,Seattle,WA,USA 772 Trends in Hospitalizations of Pregnant HIV-Infected Women in the USA: 2004–2011 Alexander Ewing 1 ; Hema Datwani 2 ; Lisa Flowers 1 ; Sascha Ellington 1 ; Denise Jamieson 1 ; Athena P. Kourtis 1 1 CDC,Atlanta,GA,USA; 2 CDC,Philadelphia,PA,USA 773 Cost-Effectiveness of Cotrimoxazole Among HIV+ Pregnant Women in Malarious Regions 2:45 PM-4:00 PM Antiretroviral Therapy Pharmacokinetics and Safety During Pregnancy and Infancy 774 Intracellular Atazanavir Concentrations Remain Stable During Pregnancy in HIVWomen Emanuele Focà 1 ; Andrea Calcagno 2 ; Andrea Bonito 1 ; Marco Simiele 2 ; Elisabetta Domeneghini 1 ; Antonio D'Avolio 2 ; Maria Antonietta Forleo 1 ; Giovanni Di Perri 2 ; Eugenia Quiros Roldan 1 ; Stefano Bonora 2 1 UnivofBrescia,Brescia, Italy; 2 UnivofTorino,Torino, Italy 775 Pharmacokinetics of Increased Dose Darunavir During Late Pregnancy and Postpartum Alice Stek 1 ; Brookie M. Best 2 ; Edmund Capparelli 2 ; JiajiaWang 3 ; David E. Shapiro 4 ;Tim R. Cressey 5 ; Elizabeth Smith 6 ; Regis Kreitchmann 7 ; Nahida Chakhtoura 8 ; Mark Mirochnick 9 1 UnivofSouthernCalifornia,LosAngeles,CA,USA; 2 UnivofCalifornia SanDiego,SanDiego,CA,USA; 3 HarvardSchofPH,Boston,MA,USA; 4 Cntr forBiostatistics inAIDSRsr,HarvardSchOfPH,Boston,MA,USA; 5 HarvardSchofPH,Boston,MA,USA; 6 NIAID,NIH,Bethesda,MD,USA; 7 SantaCasadeMisericordiadePortoAlegre,PortoAlegre,Brazil; 8 Eunice KennedyShriverNICHD,Bethesda,MD,USA; 9 BostonUnivSchofMed, Boston,MA,USA 776 High Risk of Liver Enzyme Elevation in Pregnant Women Receiving Protease Inhibitors Jeanne Sibiude 1 ; JosianeWarszawski 1 ; RolandTubiana 2 ; Jérôme Le Chenadec 3 ; Françoise Meier 4 ; Eliane Galiba 5 ; Albert Faye 6 ; Stéphane Blanche 7 ; Laurent Mandelbrot 8 ; for the ANRS CO1/CO11-EPF French Perinatal Cohort Study Group 1 CESP, INSERMU1018,LeKremlin-Bicêtre,France; 2 SorbonneUniv,Paris, France; 3 INSERM,LeKremlin-Bicêtre,France; 4 APHP,HospLouisMourier, Colombes,France; 5 CHUde l’Archet,Nice,France; 6 UnivDiderotParis7, SorbonneParis-Cité,Paris,France; 7 HospNeckerEnfantsMalades,Paris, France; 8 HospLouisMourier,Colombes,France Sung Eun Choi ; Eran Bendavid StanfordUniv,Stanford,CA,USA Session P-S2 Poster Abstracts Hall D

777 Pharmacokinetics of Daily Nevirapine in Neonates at High Risk of HIV Acquisition Tim R. Cressey 1 ; Baralee Punyawudho 2 ; Saik Urien 3 ; Gonzague Jourdain 4 ; Sophie Le Coeur 5 ; Nicole Ngo-Giang-Huong 6 ; Pra-ornsuda Sukrakanchana 7 ; Suporn Koetsawang 8 ; Marc Lallemant 9 ; for the PHPT-5 study team. Marseille,France; 5 Instd’EtudesDémographiques,Paris,Thailand; 6 Prog forHIVPreventionandTreatment/IRD175,ChiangMai,Thailand; 7 Prog forHIVPreventionandTreatment/IRD176,ChiangMai,Thailand; 8 MahidolUniv,Bangkok,Thailand; 9 Prog forHIVPreventionand Treatment/IRD174,ChiangMai,Thailand 778 Haematological Toxicity and Neonatal Prophylaxis in Infants at High MTCT Risk Elena Chiappini 1 ; Luminita Ene 2 ; Luisa Galli 1 ; Catiuscia Lisi 1 ; Ruslan Malyuta 3 ; Antoni Noguera-Julian 4 ; Pablo Rojo Conejo 5 ; Christoph Rudin 6 ; ClaireThorne 7 ; for the European Pregnancy and Paediatric HIV Cohort Collaboration in EuroCoord 1 UnivofFlorence,Florence, Italy; 2 VictorBabesHosp,Bucharest, Romania; 3 PerinatalPreventionofAIDS Initiative,Odessa,Ukraine; 4 HospSant JoandeDéu,Barcelona,Spain; 5 Hosp12deOctubre,Madrid, Spain; 6 UnivChildren’sHospBasel,Basel,Switzerland; 7 UnivCollLondon, London,UK 2:45 PM-4:00 PM Partners in Crime: CMV, HIV, and MTCT 779 Maternal CMV Urinary Shedding in HIV-Infected Women and Congenital CMV Infection Kristina Adachi 1 ; Jiahong Xu 2 ; Bonnie Ank 3 ; D. H.Watts 4 ; Esau C. Joao 5 ; Jose H. Pilotto 6 ;Yvonne J. Bryson 1 ;Valdilea G.Veloso 7 ; Lynne M. Mofenson 8 ; Karin Nielsen-Saines 1 1 UnivofCaliforniaLosAngeles,LosAngeles,CA,USA; 2 Westat, Inc, Rockville,MD,USA; 3 DavidGeffenSchofMedatUnivofCaliforniaLos Angeles,LosAngeles,CA,USA; 4 Officeof theUSGlobalAIDSCoordinator, USDeptofState,Washington,DC,USA; 5 HospFeddosServidoresdo Estado,Riode Janeiro,Brazil; 6 HospGeraldeNova Iguaçu,Riode Janeiro, Brazil; 7 Fiocruz,Riode Janeiro,Brazil; 8 PreviouslywithNIH,Bethesda, MD,USA 780 TLR9 Variant Is AssociatedWith Earlier HIV, EBV, and CMV Acquisition in Infants Kristin Beima-Sofie 1 ; Grace C. John-Stewart 1 ; DaltonWamalwa 2 ; Elizabeth Maleche-Obimbo 2 ; Jennifer Slyker 1 1 UnivofWashington,Seattle,WA,USA; 2 UnivofNairobi,Nairobi,Kenya 781 HCMV Induces CCR5 Expression, Activation and HIV Infection at Feto-Maternal Interface Erica L. Johnson 1 ; Sahithi Boggavarapu 2 ; Elan S. Johnson 2 ; Asim Lal 2 ; Parth Agrawal 2 ; Rana Chakraborty 2 1 EmoryUnivSchofMed,Atlanta,GA,USA; 2 EmoryUniv,Atlanta,GA,USA 1 HarvardSchofPH,Boston,MA,USA; 2 ChiangMaiUniv,ChiangMai, Thailand; 3 EAU08UnivParisDescartes,Paris,France; 4 IRDUMI174-PHPT, Session P-S3 Poster Abstracts Hall D

Poster Listings

70

CROI 2016